Actively Recruiting
Osteoarticular Sepsis in Intensive Care Units: A Retrospective Study of Deceased Patients
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-06-01
150
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational, retrospective, multicenter study focuses on patients who have died after being admitted to critical care units with a diagnosis of prosthetic joint infection, including infections of hip, knee, or shoulder prostheses. The study aims to improve understanding of the profiles, care pathways, and outcomes of these patients by analyzing demographic, clinical, and biological data collected between 2018 and 2022. Results will be combined with data from a related study on living patients with osteoarticular sepsis to help identify at-risk populations and enhance management strategies. The study involves collecting and reviewing data from deceased patients who were hospitalized in intensive or continuing care units for at least 48 hours with prosthetic joint infection as a primary or associated diagnosis. There are no interventions or treatments administered, as this is an observational study. Data will be analyzed over a two-year period to describe epidemiological characteristics and clinical outcomes. Participants' data will be analyzed retrospectively, with no direct involvement in the study. Researchers will assess epidemiological information, bacterial strains identified during surgery, clinical outcomes, and mortality over two years. The study is sponsored by Assistance Publique - Hôpitaux de Paris and does not involve any follow-up or treatment for participants, as it focuses on deceased patients' medical records.
CONDITIONS
Brief Title
Prosthetic Joint Infection : Lessons From Deceased Patients in Critical Care.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient aged 18 years or older
- Hospitalized in critical care (intensive or continuing care unit) between 2018 and 2022 for at least 48 hours
- Prosthetic joint infection (hip, knee, or shoulder) as primary or associated diagnosis
- Deceased patient who did not refuse data processing
You will not qualify if you...
- Infection involving osteosynthesis material
- Infection involving spinal instrumentation
- Patient with multiple infected prostheses
- Recurrence of prosthetic infection with the same microorganism as a previous episode
- Patient under legal protection
- Pregnant or breastfeeding patient
- Patient deprived of liberty
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 years
Participants who underwent intensive care with prosthetic joint infection are retrospectively observed through data collected from medical records.
No additional visits; data collected retrospectively
Trial Site Locations
Total: 1 location
1
Hôpital Lariboisière
Paris, France, France, 75010
Actively Recruiting
Research Team
B
Benjamin SOYER, MD, Msc
B
Benjamin CHOUSTERMAN, MD, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here